Who Needs the Public?
In what the company bills as the biggest private financing ever in biotechnology, Tularik raised $60 million at a post-money valuation of $330 million. Although they have been looking to go public for some time now, executives began to reconsider asthe public markets grew shakier in the summer and the fall.
You may also be interested in...
The US FDA released five device-related close-out letters in March.
Governments around the world should designate all medicines as ‘priority essential products’, the IGBA has urged, as a surge in demand coinciding with a reduction in the number of flights and rising freight costs are making it more difficult for suppliers to meet global requirements amid the coronavirus pandemic.
In a letter to the medtech industry, the FDA’s William Maisel says the US agency will hold remote meetings with device makers and other stakeholders through the end of May. The FDA also extended due dates for marketing applications by 90 days.